nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—ADRA2A—Amitriptyline—migraine	0.221	0.51	CbGbCtD
Apraclonidine—ADRA1A—Amitriptyline—migraine	0.212	0.489	CbGbCtD
Apraclonidine—Lofexidine—HTR1A—migraine	0.00847	1	CrCbGaD
Apraclonidine—Discomfort—Verapamil—migraine	0.000758	0.00204	CcSEcCtD
Apraclonidine—Dry mouth—Verapamil—migraine	0.000751	0.00202	CcSEcCtD
Apraclonidine—Bradycardia—Valproic Acid—migraine	0.000748	0.00201	CcSEcCtD
Apraclonidine—Rhinitis—Valproic Acid—migraine	0.000736	0.00198	CcSEcCtD
Apraclonidine—Oedema—Verapamil—migraine	0.000736	0.00198	CcSEcCtD
Apraclonidine—Disturbance in sexual arousal—Topiramate—migraine	0.000735	0.00198	CcSEcCtD
Apraclonidine—Haemorrhage—Valproic Acid—migraine	0.000734	0.00198	CcSEcCtD
Apraclonidine—Infection—Verapamil—migraine	0.000731	0.00197	CcSEcCtD
Apraclonidine—Pharyngitis—Valproic Acid—migraine	0.000729	0.00196	CcSEcCtD
Apraclonidine—Insomnia—Propranolol—migraine	0.000724	0.00195	CcSEcCtD
Apraclonidine—Oedema peripheral—Valproic Acid—migraine	0.000723	0.00195	CcSEcCtD
Apraclonidine—Paraesthesia—Propranolol—migraine	0.000718	0.00193	CcSEcCtD
Apraclonidine—Face oedema—Topiramate—migraine	0.000715	0.00192	CcSEcCtD
Apraclonidine—Dyspnoea—Propranolol—migraine	0.000713	0.00192	CcSEcCtD
Apraclonidine—Somnolence—Propranolol—migraine	0.000711	0.00191	CcSEcCtD
Apraclonidine—Conjunctivitis—Timolol—migraine	0.000708	0.00191	CcSEcCtD
Apraclonidine—Visual impairment—Valproic Acid—migraine	0.000708	0.00191	CcSEcCtD
Apraclonidine—Irritability—Topiramate—migraine	0.000707	0.0019	CcSEcCtD
Apraclonidine—Asthenia—Amitriptyline—migraine	0.000705	0.0019	CcSEcCtD
Apraclonidine—Pruritus—Amitriptyline—migraine	0.000695	0.00187	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Propranolol—migraine	0.000691	0.00186	CcSEcCtD
Apraclonidine—Fatigue—Propranolol—migraine	0.00069	0.00186	CcSEcCtD
Apraclonidine—Eye disorder—Valproic Acid—migraine	0.000686	0.00185	CcSEcCtD
Apraclonidine—Pain—Propranolol—migraine	0.000684	0.00184	CcSEcCtD
Apraclonidine—Constipation—Propranolol—migraine	0.000684	0.00184	CcSEcCtD
Apraclonidine—Infestation NOS—Gabapentin—migraine	0.000678	0.00183	CcSEcCtD
Apraclonidine—Infestation—Gabapentin—migraine	0.000678	0.00183	CcSEcCtD
Apraclonidine—Diarrhoea—Amitriptyline—migraine	0.000672	0.00181	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Verapamil—migraine	0.00067	0.00181	CcSEcCtD
Apraclonidine—Angiopathy—Valproic Acid—migraine	0.000666	0.00179	CcSEcCtD
Apraclonidine—Insomnia—Verapamil—migraine	0.000666	0.00179	CcSEcCtD
Apraclonidine—Bradycardia—Timolol—migraine	0.000666	0.00179	CcSEcCtD
Apraclonidine—Nasopharyngitis—Topiramate—migraine	0.000662	0.00178	CcSEcCtD
Apraclonidine—Mediastinal disorder—Valproic Acid—migraine	0.000662	0.00178	CcSEcCtD
Apraclonidine—Paraesthesia—Verapamil—migraine	0.000661	0.00178	CcSEcCtD
Apraclonidine—Conjunctivitis—Gabapentin—migraine	0.000659	0.00177	CcSEcCtD
Apraclonidine—Arrhythmia—Valproic Acid—migraine	0.000656	0.00177	CcSEcCtD
Apraclonidine—Dyspnoea—Verapamil—migraine	0.000656	0.00177	CcSEcCtD
Apraclonidine—Rhinitis—Timolol—migraine	0.000655	0.00176	CcSEcCtD
Apraclonidine—Somnolence—Verapamil—migraine	0.000654	0.00176	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Propranolol—migraine	0.000654	0.00176	CcSEcCtD
Apraclonidine—Dizziness—Amitriptyline—migraine	0.00065	0.00175	CcSEcCtD
Apraclonidine—Oedema peripheral—Timolol—migraine	0.000644	0.00173	CcSEcCtD
Apraclonidine—Mental disorder—Valproic Acid—migraine	0.000643	0.00173	CcSEcCtD
Apraclonidine—Asthma—Topiramate—migraine	0.00064	0.00172	CcSEcCtD
Apraclonidine—Fatigue—Verapamil—migraine	0.000634	0.00171	CcSEcCtD
Apraclonidine—Abdominal pain—Propranolol—migraine	0.000632	0.0017	CcSEcCtD
Apraclonidine—Visual impairment—Timolol—migraine	0.00063	0.0017	CcSEcCtD
Apraclonidine—Pain—Verapamil—migraine	0.000629	0.00169	CcSEcCtD
Apraclonidine—Constipation—Verapamil—migraine	0.000629	0.00169	CcSEcCtD
Apraclonidine—Tension—Valproic Acid—migraine	0.000627	0.00169	CcSEcCtD
Apraclonidine—Dysgeusia—Valproic Acid—migraine	0.000626	0.00169	CcSEcCtD
Apraclonidine—Vomiting—Amitriptyline—migraine	0.000625	0.00168	CcSEcCtD
Apraclonidine—Nervousness—Valproic Acid—migraine	0.000621	0.00167	CcSEcCtD
Apraclonidine—Bradycardia—Gabapentin—migraine	0.00062	0.00167	CcSEcCtD
Apraclonidine—Dermatitis—Amitriptyline—migraine	0.000619	0.00167	CcSEcCtD
Apraclonidine—Headache—Amitriptyline—migraine	0.000615	0.00166	CcSEcCtD
Apraclonidine—Abdominal discomfort—Topiramate—migraine	0.000613	0.00165	CcSEcCtD
Apraclonidine—Eye disorder—Timolol—migraine	0.000611	0.00165	CcSEcCtD
Apraclonidine—Rhinitis—Gabapentin—migraine	0.00061	0.00164	CcSEcCtD
Apraclonidine—Haemorrhage—Gabapentin—migraine	0.000609	0.00164	CcSEcCtD
Apraclonidine—Feeling abnormal—Verapamil—migraine	0.000606	0.00163	CcSEcCtD
Apraclonidine—Pharyngitis—Gabapentin—migraine	0.000604	0.00163	CcSEcCtD
Apraclonidine—Vision blurred—Valproic Acid—migraine	0.000603	0.00162	CcSEcCtD
Apraclonidine—Oedema peripheral—Gabapentin—migraine	0.0006	0.00161	CcSEcCtD
Apraclonidine—Ill-defined disorder—Valproic Acid—migraine	0.000593	0.0016	CcSEcCtD
Apraclonidine—Angiopathy—Timolol—migraine	0.000593	0.0016	CcSEcCtD
Apraclonidine—Hypersensitivity—Propranolol—migraine	0.000589	0.00159	CcSEcCtD
Apraclonidine—Mediastinal disorder—Timolol—migraine	0.000589	0.00159	CcSEcCtD
Apraclonidine—Visual impairment—Gabapentin—migraine	0.000587	0.00158	CcSEcCtD
Apraclonidine—Arrhythmia—Timolol—migraine	0.000584	0.00157	CcSEcCtD
Apraclonidine—Nausea—Amitriptyline—migraine	0.000584	0.00157	CcSEcCtD
Apraclonidine—Malaise—Valproic Acid—migraine	0.000577	0.00155	CcSEcCtD
Apraclonidine—Asthenia—Propranolol—migraine	0.000574	0.00155	CcSEcCtD
Apraclonidine—Mental disorder—Timolol—migraine	0.000573	0.00154	CcSEcCtD
Apraclonidine—Infestation NOS—Topiramate—migraine	0.000571	0.00154	CcSEcCtD
Apraclonidine—Infestation—Topiramate—migraine	0.000571	0.00154	CcSEcCtD
Apraclonidine—Erythema—Timolol—migraine	0.000569	0.00153	CcSEcCtD
Apraclonidine—Eye disorder—Gabapentin—migraine	0.000569	0.00153	CcSEcCtD
Apraclonidine—Palpitations—Valproic Acid—migraine	0.000565	0.00152	CcSEcCtD
Apraclonidine—Tension—Timolol—migraine	0.000558	0.0015	CcSEcCtD
Apraclonidine—Dysgeusia—Timolol—migraine	0.000557	0.0015	CcSEcCtD
Apraclonidine—Conjunctivitis—Topiramate—migraine	0.000555	0.00149	CcSEcCtD
Apraclonidine—Nervousness—Timolol—migraine	0.000553	0.00149	CcSEcCtD
Apraclonidine—Mediastinal disorder—Gabapentin—migraine	0.000549	0.00148	CcSEcCtD
Apraclonidine—Diarrhoea—Propranolol—migraine	0.000547	0.00147	CcSEcCtD
Apraclonidine—Chest pain—Valproic Acid—migraine	0.000544	0.00147	CcSEcCtD
Apraclonidine—Myalgia—Valproic Acid—migraine	0.000544	0.00147	CcSEcCtD
Apraclonidine—Hypersensitivity—Verapamil—migraine	0.000542	0.00146	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	0.000541	0.00146	CcSEcCtD
Apraclonidine—Discomfort—Valproic Acid—migraine	0.000538	0.00145	CcSEcCtD
Apraclonidine—Vision blurred—Timolol—migraine	0.000536	0.00144	CcSEcCtD
Apraclonidine—Mental disorder—Gabapentin—migraine	0.000533	0.00144	CcSEcCtD
Apraclonidine—Dry mouth—Valproic Acid—migraine	0.000532	0.00143	CcSEcCtD
Apraclonidine—Erythema—Gabapentin—migraine	0.00053	0.00143	CcSEcCtD
Apraclonidine—Dizziness—Propranolol—migraine	0.000529	0.00142	CcSEcCtD
Apraclonidine—Asthenia—Verapamil—migraine	0.000528	0.00142	CcSEcCtD
Apraclonidine—Oedema—Valproic Acid—migraine	0.000522	0.0014	CcSEcCtD
Apraclonidine—Bradycardia—Topiramate—migraine	0.000521	0.0014	CcSEcCtD
Apraclonidine—Pruritus—Verapamil—migraine	0.000521	0.0014	CcSEcCtD
Apraclonidine—Tension—Gabapentin—migraine	0.00052	0.0014	CcSEcCtD
Apraclonidine—Dysgeusia—Gabapentin—migraine	0.000519	0.0014	CcSEcCtD
Apraclonidine—Infection—Valproic Acid—migraine	0.000518	0.0014	CcSEcCtD
Apraclonidine—Nervousness—Gabapentin—migraine	0.000515	0.00139	CcSEcCtD
Apraclonidine—Rhinitis—Topiramate—migraine	0.000514	0.00138	CcSEcCtD
Apraclonidine—Haemorrhage—Topiramate—migraine	0.000512	0.00138	CcSEcCtD
Apraclonidine—Nervous system disorder—Valproic Acid—migraine	0.000512	0.00138	CcSEcCtD
Apraclonidine—Syncope—Timolol—migraine	0.00051	0.00137	CcSEcCtD
Apraclonidine—Vomiting—Propranolol—migraine	0.000509	0.00137	CcSEcCtD
Apraclonidine—Pharyngitis—Topiramate—migraine	0.000508	0.00137	CcSEcCtD
Apraclonidine—Skin disorder—Valproic Acid—migraine	0.000507	0.00136	CcSEcCtD
Apraclonidine—Oedema peripheral—Topiramate—migraine	0.000505	0.00136	CcSEcCtD
Apraclonidine—Dermatitis—Propranolol—migraine	0.000504	0.00136	CcSEcCtD
Apraclonidine—Diarrhoea—Verapamil—migraine	0.000503	0.00136	CcSEcCtD
Apraclonidine—Palpitations—Timolol—migraine	0.000503	0.00135	CcSEcCtD
Apraclonidine—Vision blurred—Gabapentin—migraine	0.000499	0.00134	CcSEcCtD
Apraclonidine—Visual impairment—Topiramate—migraine	0.000494	0.00133	CcSEcCtD
Apraclonidine—Ill-defined disorder—Gabapentin—migraine	0.000492	0.00132	CcSEcCtD
Apraclonidine—Dizziness—Verapamil—migraine	0.000487	0.00131	CcSEcCtD
Apraclonidine—Myalgia—Timolol—migraine	0.000485	0.0013	CcSEcCtD
Apraclonidine—Chest pain—Timolol—migraine	0.000485	0.0013	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	0.000481	0.0013	CcSEcCtD
Apraclonidine—Discomfort—Timolol—migraine	0.000479	0.00129	CcSEcCtD
Apraclonidine—Eye disorder—Topiramate—migraine	0.000479	0.00129	CcSEcCtD
Apraclonidine—Malaise—Gabapentin—migraine	0.000478	0.00129	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Valproic Acid—migraine	0.000475	0.00128	CcSEcCtD
Apraclonidine—Syncope—Gabapentin—migraine	0.000475	0.00128	CcSEcCtD
Apraclonidine—Nausea—Propranolol—migraine	0.000475	0.00128	CcSEcCtD
Apraclonidine—Dry mouth—Timolol—migraine	0.000474	0.00128	CcSEcCtD
Apraclonidine—Insomnia—Valproic Acid—migraine	0.000472	0.00127	CcSEcCtD
Apraclonidine—Paraesthesia—Valproic Acid—migraine	0.000469	0.00126	CcSEcCtD
Apraclonidine—Palpitations—Gabapentin—migraine	0.000468	0.00126	CcSEcCtD
Apraclonidine—Vomiting—Verapamil—migraine	0.000468	0.00126	CcSEcCtD
Apraclonidine—Dyspnoea—Valproic Acid—migraine	0.000465	0.00125	CcSEcCtD
Apraclonidine—Angiopathy—Topiramate—migraine	0.000465	0.00125	CcSEcCtD
Apraclonidine—Oedema—Timolol—migraine	0.000464	0.00125	CcSEcCtD
Apraclonidine—Somnolence—Valproic Acid—migraine	0.000464	0.00125	CcSEcCtD
Apraclonidine—Dermatitis—Verapamil—migraine	0.000464	0.00125	CcSEcCtD
Apraclonidine—Mediastinal disorder—Topiramate—migraine	0.000462	0.00124	CcSEcCtD
Apraclonidine—Infection—Timolol—migraine	0.000461	0.00124	CcSEcCtD
Apraclonidine—Headache—Verapamil—migraine	0.000461	0.00124	CcSEcCtD
Apraclonidine—Nervous system disorder—Timolol—migraine	0.000456	0.00123	CcSEcCtD
Apraclonidine—Chest pain—Gabapentin—migraine	0.000451	0.00121	CcSEcCtD
Apraclonidine—Myalgia—Gabapentin—migraine	0.000451	0.00121	CcSEcCtD
Apraclonidine—Skin disorder—Timolol—migraine	0.000451	0.00121	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Valproic Acid—migraine	0.00045	0.00121	CcSEcCtD
Apraclonidine—Fatigue—Valproic Acid—migraine	0.00045	0.00121	CcSEcCtD
Apraclonidine—Mental disorder—Topiramate—migraine	0.000449	0.00121	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	0.000448	0.00121	CcSEcCtD
Apraclonidine—Pain—Valproic Acid—migraine	0.000446	0.0012	CcSEcCtD
Apraclonidine—Constipation—Valproic Acid—migraine	0.000446	0.0012	CcSEcCtD
Apraclonidine—Erythema—Topiramate—migraine	0.000446	0.0012	CcSEcCtD
Apraclonidine—Discomfort—Gabapentin—migraine	0.000446	0.0012	CcSEcCtD
Apraclonidine—Dry mouth—Gabapentin—migraine	0.000441	0.00119	CcSEcCtD
Apraclonidine—Tension—Topiramate—migraine	0.000438	0.00118	CcSEcCtD
Apraclonidine—Nausea—Verapamil—migraine	0.000437	0.00118	CcSEcCtD
Apraclonidine—Dysgeusia—Topiramate—migraine	0.000437	0.00118	CcSEcCtD
Apraclonidine—Nervousness—Topiramate—migraine	0.000433	0.00117	CcSEcCtD
Apraclonidine—Oedema—Gabapentin—migraine	0.000433	0.00116	CcSEcCtD
Apraclonidine—Feeling abnormal—Valproic Acid—migraine	0.00043	0.00116	CcSEcCtD
Apraclonidine—Infection—Gabapentin—migraine	0.00043	0.00116	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Valproic Acid—migraine	0.000427	0.00115	CcSEcCtD
Apraclonidine—Nervous system disorder—Gabapentin—migraine	0.000424	0.00114	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Timolol—migraine	0.000423	0.00114	CcSEcCtD
Apraclonidine—Vision blurred—Topiramate—migraine	0.00042	0.00113	CcSEcCtD
Apraclonidine—Skin disorder—Gabapentin—migraine	0.00042	0.00113	CcSEcCtD
Apraclonidine—Insomnia—Timolol—migraine	0.00042	0.00113	CcSEcCtD
Apraclonidine—Paraesthesia—Timolol—migraine	0.000417	0.00112	CcSEcCtD
Apraclonidine—Dyspnoea—Timolol—migraine	0.000414	0.00111	CcSEcCtD
Apraclonidine—Ill-defined disorder—Topiramate—migraine	0.000414	0.00111	CcSEcCtD
Apraclonidine—Somnolence—Timolol—migraine	0.000413	0.00111	CcSEcCtD
Apraclonidine—Abdominal pain—Valproic Acid—migraine	0.000412	0.00111	CcSEcCtD
Apraclonidine—Malaise—Topiramate—migraine	0.000402	0.00108	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Timolol—migraine	0.000401	0.00108	CcSEcCtD
Apraclonidine—Fatigue—Timolol—migraine	0.0004	0.00108	CcSEcCtD
Apraclonidine—Syncope—Topiramate—migraine	0.0004	0.00108	CcSEcCtD
Apraclonidine—Pain—Timolol—migraine	0.000397	0.00107	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Gabapentin—migraine	0.000394	0.00106	CcSEcCtD
Apraclonidine—Palpitations—Topiramate—migraine	0.000394	0.00106	CcSEcCtD
Apraclonidine—Insomnia—Gabapentin—migraine	0.000391	0.00105	CcSEcCtD
Apraclonidine—Paraesthesia—Gabapentin—migraine	0.000388	0.00105	CcSEcCtD
Apraclonidine—Dyspnoea—Gabapentin—migraine	0.000386	0.00104	CcSEcCtD
Apraclonidine—Somnolence—Gabapentin—migraine	0.000385	0.00104	CcSEcCtD
Apraclonidine—Hypersensitivity—Valproic Acid—migraine	0.000384	0.00104	CcSEcCtD
Apraclonidine—Feeling abnormal—Timolol—migraine	0.000383	0.00103	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Timolol—migraine	0.00038	0.00102	CcSEcCtD
Apraclonidine—Myalgia—Topiramate—migraine	0.00038	0.00102	CcSEcCtD
Apraclonidine—Chest pain—Topiramate—migraine	0.00038	0.00102	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	0.000377	0.00102	CcSEcCtD
Apraclonidine—Discomfort—Topiramate—migraine	0.000375	0.00101	CcSEcCtD
Apraclonidine—Asthenia—Valproic Acid—migraine	0.000374	0.00101	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Gabapentin—migraine	0.000373	0.00101	CcSEcCtD
Apraclonidine—Fatigue—Gabapentin—migraine	0.000373	0.001	CcSEcCtD
Apraclonidine—Dry mouth—Topiramate—migraine	0.000371	0.001	CcSEcCtD
Apraclonidine—Pain—Gabapentin—migraine	0.00037	0.000996	CcSEcCtD
Apraclonidine—Constipation—Gabapentin—migraine	0.00037	0.000996	CcSEcCtD
Apraclonidine—Pruritus—Valproic Acid—migraine	0.000369	0.000994	CcSEcCtD
Apraclonidine—Abdominal pain—Timolol—migraine	0.000367	0.000989	CcSEcCtD
Apraclonidine—Oedema—Topiramate—migraine	0.000364	0.00098	CcSEcCtD
Apraclonidine—Infection—Topiramate—migraine	0.000362	0.000973	CcSEcCtD
Apraclonidine—Diarrhoea—Valproic Acid—migraine	0.000357	0.000961	CcSEcCtD
Apraclonidine—Nervous system disorder—Topiramate—migraine	0.000357	0.000961	CcSEcCtD
Apraclonidine—Feeling abnormal—Gabapentin—migraine	0.000356	0.00096	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Gabapentin—migraine	0.000354	0.000952	CcSEcCtD
Apraclonidine—Skin disorder—Topiramate—migraine	0.000353	0.000952	CcSEcCtD
Apraclonidine—Dizziness—Valproic Acid—migraine	0.000345	0.000929	CcSEcCtD
Apraclonidine—Hypersensitivity—Timolol—migraine	0.000342	0.000921	CcSEcCtD
Apraclonidine—Abdominal pain—Gabapentin—migraine	0.000342	0.000921	CcSEcCtD
Apraclonidine—Asthenia—Timolol—migraine	0.000333	0.000897	CcSEcCtD
Apraclonidine—Vomiting—Valproic Acid—migraine	0.000332	0.000893	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Topiramate—migraine	0.000332	0.000893	CcSEcCtD
Apraclonidine—Insomnia—Topiramate—migraine	0.000329	0.000886	CcSEcCtD
Apraclonidine—Dermatitis—Valproic Acid—migraine	0.000329	0.000885	CcSEcCtD
Apraclonidine—Pruritus—Timolol—migraine	0.000329	0.000885	CcSEcCtD
Apraclonidine—Headache—Valproic Acid—migraine	0.000327	0.00088	CcSEcCtD
Apraclonidine—Paraesthesia—Topiramate—migraine	0.000327	0.00088	CcSEcCtD
Apraclonidine—Dyspnoea—Topiramate—migraine	0.000324	0.000874	CcSEcCtD
Apraclonidine—Somnolence—Topiramate—migraine	0.000324	0.000871	CcSEcCtD
Apraclonidine—Hypersensitivity—Gabapentin—migraine	0.000319	0.000858	CcSEcCtD
Apraclonidine—Diarrhoea—Timolol—migraine	0.000318	0.000856	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Topiramate—migraine	0.000314	0.000846	CcSEcCtD
Apraclonidine—Fatigue—Topiramate—migraine	0.000314	0.000845	CcSEcCtD
Apraclonidine—Pain—Topiramate—migraine	0.000311	0.000838	CcSEcCtD
Apraclonidine—Constipation—Topiramate—migraine	0.000311	0.000838	CcSEcCtD
Apraclonidine—Asthenia—Gabapentin—migraine	0.00031	0.000836	CcSEcCtD
Apraclonidine—Nausea—Valproic Acid—migraine	0.00031	0.000834	CcSEcCtD
Apraclonidine—Dizziness—Timolol—migraine	0.000307	0.000827	CcSEcCtD
Apraclonidine—Pruritus—Gabapentin—migraine	0.000306	0.000824	CcSEcCtD
Apraclonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000305	0.00163	CbGpPWpGaD
Apraclonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000305	0.00163	CbGpPWpGaD
Apraclonidine—Feeling abnormal—Topiramate—migraine	0.0003	0.000807	CcSEcCtD
Apraclonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000299	0.0016	CbGpPWpGaD
Apraclonidine—Gastrointestinal pain—Topiramate—migraine	0.000298	0.000801	CcSEcCtD
Apraclonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000297	0.00159	CbGpPWpGaD
Apraclonidine—Diarrhoea—Gabapentin—migraine	0.000296	0.000797	CcSEcCtD
Apraclonidine—Vomiting—Timolol—migraine	0.000295	0.000795	CcSEcCtD
Apraclonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000294	0.00157	CbGpPWpGaD
Apraclonidine—Dermatitis—Timolol—migraine	0.000293	0.000788	CcSEcCtD
Apraclonidine—Headache—Timolol—migraine	0.000291	0.000783	CcSEcCtD
Apraclonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000291	0.00156	CbGpPWpGaD
Apraclonidine—Abdominal pain—Topiramate—migraine	0.000288	0.000775	CcSEcCtD
Apraclonidine—Dizziness—Gabapentin—migraine	0.000286	0.00077	CcSEcCtD
Apraclonidine—ADRA2C—Signaling by GPCR—RAMP1—migraine	0.000286	0.00153	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CALCRL—migraine	0.000286	0.00153	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000284	0.00152	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000281	0.0015	CbGpPWpGaD
Apraclonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.00028	0.0015	CbGpPWpGaD
Apraclonidine—Nausea—Timolol—migraine	0.000276	0.000743	CcSEcCtD
Apraclonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000276	0.00148	CbGpPWpGaD
Apraclonidine—Vomiting—Gabapentin—migraine	0.000275	0.00074	CcSEcCtD
Apraclonidine—ADRA1A—GPCR downstream signaling—CALCRL—migraine	0.000275	0.00147	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—RAMP1—migraine	0.000275	0.00147	CbGpPWpGaD
Apraclonidine—Dermatitis—Gabapentin—migraine	0.000272	0.000734	CcSEcCtD
Apraclonidine—Headache—Gabapentin—migraine	0.000271	0.00073	CcSEcCtD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000271	0.00145	CbGpPWpGaD
Apraclonidine—Hypersensitivity—Topiramate—migraine	0.000268	0.000722	CcSEcCtD
Apraclonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000267	0.00143	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000267	0.00143	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000267	0.00143	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—HTR1B—migraine	0.000262	0.0014	CbGpPWpGaD
Apraclonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000262	0.0014	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000261	0.0014	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000261	0.0014	CbGpPWpGaD
Apraclonidine—Asthenia—Topiramate—migraine	0.000261	0.000703	CcSEcCtD
Apraclonidine—Pruritus—Topiramate—migraine	0.000257	0.000693	CcSEcCtD
Apraclonidine—Nausea—Gabapentin—migraine	0.000257	0.000692	CcSEcCtD
Apraclonidine—ADRA2A—GPCR downstream signaling—RAMP1—migraine	0.000255	0.00137	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CALCRL—migraine	0.000255	0.00137	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000254	0.00136	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—HTR1A—migraine	0.000252	0.00135	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000252	0.00135	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—RAMP1—migraine	0.00025	0.00134	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CALCRL—migraine	0.00025	0.00134	CbGpPWpGaD
Apraclonidine—Diarrhoea—Topiramate—migraine	0.000249	0.00067	CcSEcCtD
Apraclonidine—ADRA2B—GPCR ligand binding—TAC1—migraine	0.000249	0.00133	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—NPS—migraine	0.000249	0.00133	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000248	0.00133	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000248	0.00133	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000248	0.00133	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—HTR1B—migraine	0.000245	0.00131	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR1D—migraine	0.000245	0.00131	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—HTR2C—migraine	0.000244	0.0013	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000243	0.0013	CbGpPWpGaD
Apraclonidine—ADRA1A—G alpha (q) signalling events—HTR2A—migraine	0.000242	0.0013	CbGpPWpGaD
Apraclonidine—Dizziness—Topiramate—migraine	0.000241	0.000648	CcSEcCtD
Apraclonidine—ADRA2B—GPCR ligand binding—EDNRA—migraine	0.000237	0.00127	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000236	0.00126	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—HTR1A—migraine	0.000236	0.00126	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—NPS—migraine	0.000232	0.00124	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—TAC1—migraine	0.000232	0.00124	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—RAMP1—migraine	0.000232	0.00124	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CALCRL—migraine	0.000232	0.00124	CbGpPWpGaD
Apraclonidine—Vomiting—Topiramate—migraine	0.000231	0.000623	CcSEcCtD
Apraclonidine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000229	0.00123	CbGpPWpGaD
Apraclonidine—Dermatitis—Topiramate—migraine	0.000229	0.000617	CcSEcCtD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000229	0.00123	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR1D—migraine	0.000229	0.00122	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—CALCA—migraine	0.000228	0.00122	CbGpPWpGaD
Apraclonidine—Headache—Topiramate—migraine	0.000228	0.000614	CcSEcCtD
Apraclonidine—ADRA2C—GPCR ligand binding—HTR2C—migraine	0.000228	0.00122	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR2B—migraine	0.000227	0.00122	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR1D—migraine	0.000222	0.00119	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—EDNRA—migraine	0.000222	0.00119	CbGpPWpGaD
Apraclonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000217	0.00116	CbGpPWpGaD
Apraclonidine—Nausea—Topiramate—migraine	0.000216	0.000582	CcSEcCtD
Apraclonidine—ADRA1A—GPCR ligand binding—HTR1B—migraine	0.000214	0.00115	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000214	0.00115	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—HTR7—migraine	0.000214	0.00114	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—CALCA—migraine	0.000213	0.00114	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000213	0.00114	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR2B—migraine	0.000212	0.00114	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR1D—migraine	0.000208	0.00111	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR2B—migraine	0.000207	0.00111	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—HTR1A—migraine	0.000206	0.0011	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—NPS—migraine	0.000203	0.00109	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—TAC1—migraine	0.000203	0.00109	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR1D—migraine	0.0002	0.00107	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—HTR7—migraine	0.0002	0.00107	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—HTR2C—migraine	0.000199	0.00107	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—HTR1B—migraine	0.000199	0.00106	CbGpPWpGaD
Apraclonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000196	0.00105	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—EDNRA—migraine	0.000194	0.00104	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR2B—migraine	0.000193	0.00103	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—HTR1A—migraine	0.000192	0.00102	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—NPS—migraine	0.000189	0.00101	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—TAC1—migraine	0.000189	0.00101	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000187	0.001	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—CALCA—migraine	0.000186	0.000998	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR2B—migraine	0.000186	0.000994	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR1D—migraine	0.000186	0.000993	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—HTR2C—migraine	0.000185	0.00099	CbGpPWpGaD
Apraclonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000183	0.000982	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR1D—migraine	0.000181	0.000971	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CALCRL—migraine	0.000181	0.000966	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—RAMP1—migraine	0.000181	0.000966	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—EDNRA—migraine	0.00018	0.000963	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—HTR7—migraine	0.000174	0.000933	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000174	0.000931	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—CALCA—migraine	0.000173	0.000927	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR2B—migraine	0.000173	0.000923	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CALCRL—migraine	0.000169	0.000903	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—RAMP1—migraine	0.000169	0.000903	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR2B—migraine	0.000169	0.000902	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR1D—migraine	0.000169	0.000902	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—HTR7—migraine	0.000162	0.000867	CbGpPWpGaD
Apraclonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.00016	0.000858	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR2B—migraine	0.000157	0.000838	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CACNA1A—migraine	0.000153	0.000818	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR ligand binding—HTR2A—migraine	0.00015	0.0008	CbGpPWpGaD
Apraclonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.000149	0.000797	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR1B—migraine	0.000148	0.000793	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—RAMP1—migraine	0.000148	0.000789	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CALCRL—migraine	0.000148	0.000789	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR1A—migraine	0.000143	0.000763	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—NPS—migraine	0.000141	0.000752	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—TAC1—migraine	0.000141	0.000752	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR ligand binding—HTR2A—migraine	0.00014	0.000748	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR1B—migraine	0.000138	0.000741	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR2C—migraine	0.000138	0.000737	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CALCRL—migraine	0.000137	0.000733	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—RAMP1—migraine	0.000137	0.000733	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR1B—migraine	0.000135	0.00072	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—EDNRA—migraine	0.000134	0.000717	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR1A—migraine	0.000133	0.000713	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—TAC1—migraine	0.000131	0.000702	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—NPS—migraine	0.000131	0.000702	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR1D—migraine	0.000131	0.000702	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR1A—migraine	0.00013	0.000693	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CALCA—migraine	0.000129	0.00069	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR2C—migraine	0.000129	0.000689	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—TAC1—migraine	0.000128	0.000683	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—NPS—migraine	0.000128	0.000683	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR1B—migraine	0.000126	0.000673	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—EDNRA—migraine	0.000125	0.00067	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR2C—migraine	0.000125	0.00067	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CACNA1A—migraine	0.000124	0.000665	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR1D—migraine	0.000123	0.000656	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR ligand binding—HTR2A—migraine	0.000122	0.000654	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR2B—migraine	0.000122	0.000653	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—EDNRA—migraine	0.000122	0.000651	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR1B—migraine	0.000121	0.000648	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR1A—migraine	0.000121	0.000648	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR7—migraine	0.000121	0.000646	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CALCA—migraine	0.000121	0.000645	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—TAC1—migraine	0.000119	0.000638	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—NPS—migraine	0.000119	0.000638	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CALCA—migraine	0.000117	0.000627	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR2C—migraine	0.000117	0.000625	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR1A—migraine	0.000117	0.000623	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—NPS—migraine	0.000115	0.000614	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—TAC1—migraine	0.000115	0.000614	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR2B—migraine	0.000114	0.00061	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—EDNRA—migraine	0.000114	0.000608	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—HTR2A—migraine	0.000113	0.000607	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR7—migraine	0.000113	0.000603	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR2C—migraine	0.000113	0.000602	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR1B—migraine	0.000112	0.000602	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR1B—migraine	0.00011	0.000588	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR7—migraine	0.00011	0.000586	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—EDNRA—migraine	0.000109	0.000586	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CALCA—migraine	0.000109	0.000586	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR1A—migraine	0.000108	0.000579	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—LRP1—migraine	0.000107	0.000575	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR1D—migraine	0.000107	0.000573	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—TAC1—migraine	0.000107	0.00057	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—NPS—migraine	0.000107	0.00057	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR1A—migraine	0.000106	0.000566	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CALCA—migraine	0.000105	0.000564	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR2C—migraine	0.000105	0.000559	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—TAC1—migraine	0.000104	0.000558	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—NPS—migraine	0.000104	0.000558	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR7—migraine	0.000102	0.000548	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR2C—migraine	0.000102	0.000547	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR1B—migraine	0.000102	0.000546	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—EDNRA—migraine	0.000102	0.000544	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—LRP1—migraine	0.0001	0.000537	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR2B—migraine	9.96e-05	0.000533	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR1D—migraine	9.96e-05	0.000533	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—EDNRA—migraine	9.94e-05	0.000532	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR7—migraine	9.86e-05	0.000527	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR1A—migraine	9.83e-05	0.000526	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CALCA—migraine	9.79e-05	0.000524	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—TAC1—migraine	9.68e-05	0.000518	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—NPS—migraine	9.68e-05	0.000518	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CALCA—migraine	9.57e-05	0.000512	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR2C—migraine	9.49e-05	0.000508	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR2B—migraine	9.26e-05	0.000495	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—EDNRA—migraine	9.24e-05	0.000494	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR7—migraine	9.16e-05	0.00049	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR7—migraine	8.95e-05	0.000479	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CALCA—migraine	8.89e-05	0.000476	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—LRP1—migraine	8.77e-05	0.000469	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—HTR2A—migraine	8.45e-05	0.000452	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR7—migraine	8.32e-05	0.000445	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NOTCH4—migraine	8.24e-05	0.000441	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—LRP1—migraine	8.15e-05	0.000436	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR1B—migraine	7.95e-05	0.000425	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—HTR2A—migraine	7.9e-05	0.000422	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NOTCH4—migraine	7.7e-05	0.000412	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—HTR2A—migraine	7.68e-05	0.000411	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR1A—migraine	7.65e-05	0.00041	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NPS—migraine	7.54e-05	0.000403	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TAC1—migraine	7.54e-05	0.000403	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PGR—migraine	7.54e-05	0.000403	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR1B—migraine	7.43e-05	0.000397	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR2C—migraine	7.39e-05	0.000396	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—EDNRA—migraine	7.19e-05	0.000385	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—HTR2A—migraine	7.17e-05	0.000384	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR1A—migraine	7.15e-05	0.000383	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PGR—migraine	7.04e-05	0.000377	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TAC1—migraine	7.04e-05	0.000377	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NPS—migraine	7.04e-05	0.000377	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NOTCH3—migraine	7.01e-05	0.000375	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CALCA—migraine	6.92e-05	0.00037	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR2C—migraine	6.91e-05	0.000369	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—HTR2A—migraine	6.9e-05	0.000369	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NOTCH4—migraine	6.73e-05	0.00036	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—EDNRA—migraine	6.72e-05	0.000359	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NOTCH3—migraine	6.55e-05	0.00035	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR1B—migraine	6.49e-05	0.000347	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR7—migraine	6.47e-05	0.000346	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CALCA—migraine	6.47e-05	0.000346	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—HTR2A—migraine	6.41e-05	0.000343	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—HTR2A—migraine	6.27e-05	0.000335	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NOTCH4—migraine	6.25e-05	0.000335	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR1A—migraine	6.25e-05	0.000334	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NPS—migraine	6.16e-05	0.000329	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PGR—migraine	6.16e-05	0.000329	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TAC1—migraine	6.16e-05	0.000329	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR7—migraine	6.05e-05	0.000324	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR2C—migraine	6.04e-05	0.000323	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR1B—migraine	6.03e-05	0.000323	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—EDNRA—migraine	5.87e-05	0.000314	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—HTR2A—migraine	5.82e-05	0.000312	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR1A—migraine	5.81e-05	0.000311	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NOTCH3—migraine	5.72e-05	0.000306	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NPS—migraine	5.72e-05	0.000306	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PGR—migraine	5.72e-05	0.000306	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TAC1—migraine	5.72e-05	0.000306	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CALCA—migraine	5.65e-05	0.000302	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR2C—migraine	5.61e-05	0.0003	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TGFBR2—migraine	5.58e-05	0.000298	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—EDNRA—migraine	5.46e-05	0.000292	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NOTCH3—migraine	5.32e-05	0.000284	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR7—migraine	5.29e-05	0.000283	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CALCA—migraine	5.25e-05	0.000281	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TGFBR2—migraine	5.21e-05	0.000279	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—MTHFR—migraine	5.06e-05	0.000271	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR7—migraine	4.91e-05	0.000263	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TGFBR2—migraine	4.55e-05	0.000244	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—HTR2A—migraine	4.53e-05	0.000243	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—HTR2A—migraine	4.24e-05	0.000227	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TGFBR2—migraine	4.23e-05	0.000226	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—MTHFR—migraine	4.11e-05	0.00022	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—ESR1—migraine	4.03e-05	0.000215	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ESR1—migraine	3.76e-05	0.000201	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—HTR2A—migraine	3.7e-05	0.000198	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—HTR2A—migraine	3.44e-05	0.000184	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ESR1—migraine	3.29e-05	0.000176	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ESR1—migraine	3.05e-05	0.000163	CbGpPWpGaD
